Cyclin-dependent kinase 2 controls peripheral immune tolerance

Journal of Immunology

Volumn 189, Issue 12, 2012, Pages 5659-5666

  Chunder, Neelanjana ^a   Wang, Liqing ^a   Chen, Chunxia ^a   Hancock, Wayne W ^a   Wells, Andrew D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GAMMA INTERFERON; INTERLEUKIN 2; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR FOXP3;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENTERITIS; ENZYME MECHANISM; FEMALE; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; UPREGULATION;

ANIMALS; CELLS, CULTURED; COLITIS; CYCLIN-DEPENDENT KINASE 2; DISEASE MODELS, ANIMAL; FEMALE; IMMUNE TOLERANCE; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, 129 STRAIN; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; MICE, TRANSGENIC; T-LYMPHOCYTES, REGULATORY;

EID: 84871150208     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202313     Document Type: Article

References (51)

1. Wells, A. D. 2009. New insights into the molecular basis of T cell anergy: anergy factors, avoidance sensors, and epigenetic imprinting. J. Immunol. 182: 7331-7341.
2. Polyak, K., M.-H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massagué. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
3. Boussiotis, V. A., G. J. Freeman, P. A. Taylor, A. Berezovskaya, I. Grass, B. R. Blazar, and L. M. Nadler. 2000. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat. Med. 6: 290-297. (Pubitemid 30148621)
4. Rowell, E. A., M. C. Walsh, and A. D. Wells. 2005. Opposing roles for the cyclin-dependent kinase inhibitor p27kip1 in the control of CD4+ T cell proliferation and effector function. J. Immunol. 174: 3359-3368. (Pubitemid 40354040)
5. Rowell, E. A., L. Wang, W. W. Hancock, and A. D. Wells. 2006. The cyclin-dependent kinase inhibitor p27kip1 is required for transplantation tolerance induced by costimulatory blockade. J. Immunol. 177: 5169-5176. (Pubitemid 44527589)
6. Li, L., Y. Iwamoto, A. Berezovskaya, and V. A. Boussiotis. 2006. A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance. Nat. Immunol. 7: 1157-1165. (Pubitemid 44594311)
7. Besson, A., M. Gurian-West, A. Schmidt, A. Hall, and J. M. Roberts. 2004. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev. 18: 862-876. (Pubitemid 38529656)
8. Tomoda, K., Y. Kubota, and J. Kato. 1999. Degradation of the cyclin-dependentkinase inhibitor p27Kip1 is instigated by Jab1. Nature 398: 160-165.
9. Chopra, S., S. Fernandez De Mattos, E. W. Lam, and D. J. Mann. 2002. Jab1 coactivation of c-Jun is abrogated by the serine 10-phosphorylated form of p27Kip1. J. Biol. Chem. 277: 32413-32416. (Pubitemid 34984740)
10. Ishida, N., T. Hara, T. Kamura, M. Yoshida, K. Nakayama, and K. I. Nakayama. 2002. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277: 14355-14358. (Pubitemid 34952496)
11. Satyanarayana, A., and P. Kaldis. 2009. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 28: 2925-2939.
12. Berthet, C., E. Aleem, V. Coppola, L. Tessarollo, and P. Kaldis. 2003. Cdk2 knockout mice are viable. Curr. Biol. 13: 1775-1785. (Pubitemid 37274109)
13. Chen, C., E. A. Rowell, R. M. Thomas, W. W. Hancock, and A. D. Wells. 2006. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J. Biol. Chem. 281: 36828-36834. (Pubitemid 46042151)
14. Sicinska, E., I. Aifantis, L. Le Cam, W. Swat, C. Borowski, Q. Yu, A. A. Ferrando, S. D. Levin, Y. Geng, H. von Boehmer, and P. Sicinski. 2003. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 4: 451-461. (Pubitemid 38050042)
15. Suchin, E. J., P. B. Langmuir, E. Palmer, M. H. Sayegh, A. D. Wells, and L. A. Turka. 2001. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166: 973-981. (Pubitemid 32060253)
16. Berthet, C., M. C. Rodriguez-Galan, D. L. Hodge, J. Gooya, V. Pascal, H. A. Young, J. Keller, R. Bosselut, and P. Kaldis. 2007. Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2. Mol. Cell. Biol. 27: 5079-5089. (Pubitemid 47068283)
17. Geng, Y., Q. Yu, E. Sicinska, M. Das, J. E. Schneider, S. Bhattacharya, W. M. Rideout, R. T. Bronson, H. Gardner, and P. Sicinski. 2003. Cyclin E ablation in the mouse. Cell 114: 431-443. (Pubitemid 37100992)
18. Powrie, F., R. Correa-Oliveira, S. Mauze, and R. L. Coffman. 1994. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179: 589-600.
19. Buckler, J. L., P. T. Walsh, P. M. Porrett, Y. Choi, and L. A. Turka. 2006. Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN. J. Immunol. 177: 4262-4266. (Pubitemid 44469752)
20. Fero, M. L., M. Rivkin, M. Tasch, P. Porter, C. E. Carow, E. Firpo, K. Polyak, L. H. Tsai, V. Broudy, R. M. Perlmutter, et al. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27 (Kip1)-deficient mice. Cell 85: 733-744.
21. Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, D. Y. Loh, and K. Nakayama. 1996. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85: 707-720.
22. Kiyokawa, H., R. D. Kineman, K. O. Manova-Todorova, V. C. Soares, E. S. Hoffman, M. Ono, D. Khanam, A. C. Hayday, L. A. Frohman, and A. Koff. 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85: 721-732.
23. Wolfraim, L. A., and J. J. Letterio. 2005. Cutting edge: p27Kip1 deficiency reduces the requirement for CD28-mediated costimulation in naive CD8+ but not CD4+ T lymphocytes. J. Immunol. 174: 2481-2484. (Pubitemid 40279658)
24. Singh, A., A. Jatzek, E. H. Plisch, R. Srinivasan, J. Svaren, and M. Suresh. 2010. Regulation of memory CD8 T-cell differentiation by cyclin-dependent kinase inhibitor p27Kip1. Mol. Cell. Biol. 30: 5145-5159.
25. Malumbres, M., and M. Barbacid. 2005. Mammalian cyclin-dependent kinases. Trends Biochem. Sci. 30: 630-641. (Pubitemid 41540083)
26. Santamaría, D., C. Barrière, A. Cerqueira, S. Hunt, C. Tardy, K. Newton, J. F. Cáceres, P. Dubus, M. Malumbres, and M. Barbacid. 2007. Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448: 811-815. (Pubitemid 47266342)
27. Ortega, S., I. Prieto, J. Odajima, A. Martín, P. Dubus, R. Sotillo, J. L. Barbero, M. Malumbres, and M. Barbacid. 2003. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat. Genet. 35: 25-31. (Pubitemid 37048592)
28. Wells, A. D. 2007. Cyclin-dependent kinases: molecular switches controlling anergy and potential therapeutic targets for tolerance. Semin. Immunol. 19: 173-179. (Pubitemid 46824072)
29. Laurence, A., C. M. Tato, T. S. Davidson, Y. Kanno, Z. Chen, Z. Yao, R. B. Blank, F. Meylan, R. Siegel, L. Hennighausen, et al. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26: 371-381. (Pubitemid 46413906)
30. Yang, X.-P., K. Ghoreschi, S. M. Steward-Tharp, J. Rodriguez-Canales, J. Zhu, J. R. Grainger, K. Hirahara, H.-W. Sun, L. Wei, G. Vahedi, et al. 2011. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 12: 247-254.
31. Johnston, R. J., Y. S. Choi, J. A. Diamond, J. A. Yang, and S. Crotty. 2012. STAT5 is a potent negative regulator of TFH cell differentiation. J. Exp. Med. 209: 243-250.
32. Shi, M., T. H. Lin, K. C. Appell, and L. J. Berg. 2008. Janus-kinase-3-dependent signals induce chromatin remodeling at the Ifng locus during T helper 1 cell differentiation. Immunity 28: 763-773. (Pubitemid 351778407)
33. Pepper, M., A. J. Pagán, B. Z. Igyártó, J. J. Taylor, and M. K. Jenkins. 2011. Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity 35: 583-595.
34. Liao, W., J.-X. Lin, L. Wang, P. Li, and W. J. Leonard. 2011. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat. Immunol. 12: 551-559.
35. Cote-Sierra, J., G. Foucras, L. Guo, L. Chiodetti, H. A. Young, J. Hu-Li, J. Zhu, and W. E. Paul. 2004. Interleukin 2 plays a central role in Th2 differentiation. Proc. Natl. Acad. Sci. USA 101: 3880-3885. (Pubitemid 38381071)
36. Zheng, S. G., J. Wang, P. Wang, J. D. Gray, and D. A. Horwitz. 2007. IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J. Immunol. 178: 2018-2027. (Pubitemid 46233398)
37. Davidson, T. S., R. J. DiPaolo, J. Andersson, and E. M. Shevach. 2007. Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J. Immunol. 178: 4022-4026. (Pubitemid 46492349)
38. Vanden Bush, T. J., and G. A. Bishop. 2011. CDK-mediated regulation of cell functions via c-Jun phosphorylation and AP-1 activation. PLoS ONE 6: e19468.
39. Biggs, J. R., L. F. Peterson, Y. Zhang, A. S. Kraft, and D.-E. Zhang. 2006. AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complex. Mol. Cell. Biol. 26: 7420-7429. (Pubitemid 44547694)
40. Guo, H., and A. D. Friedman. 2011. Phosphorylation of RUNX1 by cyclin-dependent kinase reduces direct interaction with HDAC1 and HDAC3. J. Biol. Chem. 286: 208-215.
41. Haidweger, E., M. Novy, and H. Rotheneder. 2001. Modulation of Sp1 activity by a cyclin A/CDK complex. J. Mol. Biol. 306: 201-212. (Pubitemid 33032874)
42. Banchio, C., L. M. Schang, and D. E. Vance. 2004. Phosphorylation of Sp1 by cyclin-dependent kinase 2 modulates the role of Sp1 in CTP:phosphocholine cytidylyltransferase alpha regulation during the S phase of the cell cycle. J. Biol. Chem. 279: 40220-40226. (Pubitemid 39258298)
43. Matsuura, I., N. G. Denissova, G. Wang, D. He, J. Long, and F. Liu. 2004. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430: 226-231. (Pubitemid 38902433)
44. Perkins, N. D., L. K. Felzien, J. C. Betts, K. Leung, D. H. Beach, and G. J. Nabel. 1997. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275: 523-527. (Pubitemid 27051906)
45. Chen, S., L. R. Bohrer, A. N. Rai, Y. Pan, L. Gan, X. Zhou, A. Bagchi, J. A. Simon, and H. Huang. 2010. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat. Cell Biol. 12: 1108-1114.
46. Hale, T. K., A. Contreras, A. J. Morrison, and R. E. Herrera. 2006. Phosphorylation of the linker histone H1 by CDK regulates its binding to HP1alpha. Mol. Cell 22: 693-699. (Pubitemid 43817599)
47. Contreras, A., T. K. Hale, D. L. Stenoien, J. M. Rosen, M. A. Mancini, and R. E. Herrera. 2003. The dynamic mobility of histone H1 is regulated by cyclin/ CDK phosphorylation. Mol. Cell. Biol. 23: 8626-8636. (Pubitemid 37433367)
48. Li, Z., D. I. Dordai, J. Lee, and S. Desiderio. 1996. A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle. Immunity 5: 575-589. (Pubitemid 27062067)
49. Nutley, B. P., F. I. Raynaud, S. C. Wilson, P. M. Fischer, A. Hayes, P. M. Goddard, S. J. McClue, M. Jarman, D. P. Lane, and P. Workman. 2005. Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor Rroscovitine in the mouse. Mol. Cancer Ther. 4: 125-139. (Pubitemid 40276782)
50. Li, L., H. Wang, J. S. Kim, G. Pihan, and V. Boussiotis. 2009. The cyclin dependent kinase inhibitor (R)-roscovitine prevents alloreactive T cell clonal expansion and protects against acute GvHD. Cell Cycle 8: 1794-1802.
51. Wells, A. D., H. Gudmundsdottir, and L. A. Turka. 1997. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100: 3173-3183. (Pubitemid 28022856)